Jason Bablak
Chief Operating Officer at Attune Pharmaceuticals, Inc.
Network origin in Jason Bablak first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Lev Pharmaceuticals, Inc.
 Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lev Pharmaceuticals, Inc. develops and commercializes therapeutic products for the treatment of inflammatory diseases. It researches a series of drugs to fight both edema and heart attacks. The company was founded on July 21, 2003 and is headquartered in New York, NY.
13
| Subsidiary | Pharmaceuticals: Major | 13 |
Attune Pharmaceuticals, Inc.
 Attune Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Attune Pharmaceuticals, Inc. engages in the provision of biotechnology services. It discovers and develops orally-administered small-molecule therapeutics for the treatment of rare diseases. The company was founded by Andrew Ian McDonald and is headquartered in New York, NY.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Plasma Protein Therapeutics Association
 Plasma Protein Therapeutics Association Miscellaneous Commercial ServicesCommercial Services The Plasma Protein Therapeutics Association is a non-profit organization that represents manufacturers and plasma collection centers. The private company is based in Washington and has subsidiaries in the United States. Anita Brikman has been the CEO of the American company since 2023.
1
| Private Company | Miscellaneous Commercial Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jason Bablak via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| SYNVISTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| JLM COUTURE, INC. | Apparel/Footwear | Director of Finance/CFO | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Chief Operating Officer | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| SIGA TECHNOLOGIES, INC. | Pharmaceuticals: Major | Chairman President | |
Alta Partners Management Co. LP
 Alta Partners Management Co. LP Investment ManagersFinance Alta Partners Management Co. LP (Alta Partners) is a venture capital firm founded in 1996 by Jean Deleage, Guy Paul Nohra, Marino Polestra and Garrett P. Gruener. The firm is headquartered in Jackson, Wyoming. | Investment Managers | Private Equity Investor | |
OraPharma, Inc.
 OraPharma, Inc. Pharmaceuticals: MajorHealth Technology OraPharma, Inc. develops and produces drugs for oral diseases. It offers a suite of products to address a range of patient concerns from the foundation of gums, bone, and teeth to the aesthetics of a whiter smile. The company's products include ARESTIN Microspheres, a locally administered antibiotic indicated as an adjunct to scaling and root planning procedures for the reduction of pocket depth in patients with adult periodontitis; and ONSET Approach, a unique delivery system of locally buffered anesthesia that provides faster onset of anesthesia and a comfortable injection. The company was founded in 1996 and is headquartered in Horsham, PA. | Pharmaceuticals: Major | Chief Operating Officer Comptroller/Controller/Auditor Corporate Officer/Principal | |
| ACHILLION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer Public Communications Contact | |
| FEMASYS INC. | Electronic Equipment/Instruments | Director of Finance/CFO | |
Tetragenex Pharmaceuticals, Inc.
 Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY. | Pharmaceuticals: Major | Director of Finance/CFO | |
| ZS PHARMA INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Althera Medical Ltd.
 Althera Medical Ltd. Medical SpecialtiesHealth Technology Althera Medical Ltd. develops therapeutic devices for the treatment of various cancers. The private company is based in Bnei Braq, Israel. | Medical Specialties | Director of Finance/CFO | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Undergraduate Degree | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Masters Business Admin Undergraduate Degree | |
Prism Venture Management LLC
 Prism Venture Management LLC Investment ManagersFinance Prism Venture Management LLC (Prism Venture Management) is a venture capital firm founded in 1996 by Bob C. Fleming and John L. Brooks. The firm is headquartered in Needham, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Brooklyn College | College/University | Undergraduate Degree | |
| Fairleigh Dickinson University | College/University | Undergraduate Degree | |
| LaSalle University | College/University | Undergraduate Degree | |
| St. Joseph's University | College/University | Masters Business Admin Masters Business Admin | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California, Irvine | College/University | Doctorate Degree Doctorate Degree | |
| Yeshiva University | College/University | Doctorate Degree Undergraduate Degree | |
New York State Society of Certified Public Accountants
 New York State Society of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services New York State Society of Certified Public Accountants is a non-profit organization. It provides a membership program for certified public accountants that offers in-person and online networking opportunities, Continuing Professional Education courses and conferences, the CPA Journal, and other publications. The company was foudned in 1897 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director of Finance/CFO | |
| Lev Development Corp. | Chairman Chief Executive Officer | ||
| IBIO, INC. | Pharmaceuticals: Other | Director of Finance/CFO | |
Relmada Therapeutics, Inc. /Old/
 Relmada Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Relmada Therapeutics, Inc. is a holding company, which engages in the development of pharmaceutical drugs for the treatment of acute and chronic pains. It focuses in the developing of chronic pain due to cancer, musculoskeletal disorders, and peripheral neuropathy. The company was founded in 2000 and is headquartered in Blue Bell, PA. | Pharmaceuticals: Major | Director of Finance/CFO | |
| UNIQURE N.V. | Biotechnology | Corporate Officer/Principal | |
| CELLECTAR BIOSCIENCES, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| RELMADA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| BEYOND AIR, INC. | Medical Specialties | Director of Finance/CFO | |
Beyond Air Ltd.
 Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | Biotechnology | Director of Finance/CFO | |
| AKARI THERAPEUTICS, PLC | Biotechnology | Director of Finance/CFO | |
| SHIFTPIXY, INC. | Personnel Services | Director of Finance/CFO | |
IEcure, Inc.
 IEcure, Inc. BiotechnologyHealth Technology iECURE, Inc. is a gene editing company that focuses on developing therapies for liver disorders with significant unmet need. The company is based in Plymouth Meeting, PA, and the CEO of the company is Joseph Truitt. The company's approach involves mutation-agnostic in vivo gene insertion or knock-in editing, which has the potential to replace and restore the function of a dysfunctional gene, regardless of mutation. iECURE collaborates with the University of Pennsylvania's Gene Therapy Program to utilize their translational expertise and infrastructure. The company's management team has extensive experience in executing orphan drug and gene therapy clinical trials and successfully commercializing multiple products. iECURE's programs are currently focused on developing in vivo gene insertion therapies for the treatment of rare pediatric liver diseases. | Biotechnology | Chief Executive Officer Chief Operating Officer | |
LifeSci Acquisition III Corp.
 LifeSci Acquisition III Corp. Financial ConglomeratesFinance LifeSci Acquisition III Corp. operates as a blank check company with the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on December 18, 2019 and is headquartered in new York, NY. | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
LifeSci Venture Partners
 LifeSci Venture Partners Investment ManagersFinance LifeSci Venture Partners (LifeSci Venture Partners) is a venture capital subsidiary of LifeSci Index Partners LLC founded in 2017 by Paul Inho Yook. The firm is headquartered in New York. | Investment Managers | Chief Executive Officer Corporate Officer/Principal | |
| LARIMAR THERAPEUTICS, INC. | Biotechnology | Chairman | |
Code Biotherapeutics, Inc.
 Code Biotherapeutics, Inc. BiotechnologyHealth Technology Code Biotherapeutics, Inc. is a next-generation gene therapy company based in Greater Philadelphia. The American company is focused on developing targeted non-viral gene therapies to treat serious and life-threatening genetic diseases. The company uses a novel multivalent synthetic DNA delivery platform called 3DNA, which overcomes many of the challenges associated with viral-based gene therapies. Code Biotherapeutics is advancing an internal pipeline focused on select rare disease programs and establishing partnerships to take forward programs in both rare and prevalent diseases. Code Biotherapeutics is supported by top-tier investors that believe in their work to drive discovery programs forward as they aim to deliver on the promise of their proprietary synthetic DNA-based, non-viral genetic medicines delivery platform. The company was founded by Brian P. McVeigh, who has been the CEO since incorporation. | Biotechnology | Director/Board Member |
Statistics
International
| United States | 44 |
| Israel | 4 |
| United Kingdom | 3 |
| Netherlands | 2 |
Sectoral
| Health Technology | 30 |
| Consumer Services | 10 |
| Finance | 5 |
| Commercial Services | 5 |
| Consumer Non-Durables | 2 |
Operational
| Director/Board Member | 52 |
| Corporate Officer/Principal | 41 |
| Chief Executive Officer | 22 |
| Director of Finance/CFO | 19 |
| Undergraduate Degree | 16 |
Most connected contacts
| Insiders | |
|---|---|
| Thomas Heinrich Glanzmann | 24 |
| Eric Richman | 22 |
| Andrew McDonald | 19 |
| Rod Wong | 15 |
| Douglas Beck | 14 |
| Joshua D. Schein | 12 |
| Ira N. Kalfus | 11 |
| Dov Elefant | 10 |
| Scott G. Eagle | 10 |
| Joseph Truitt | 10 |
| Adam Tomasi | 10 |
| Paul Firuta | 10 |
| Judson A. Cooper | 10 |
| Susanne Heinzinger | 5 |
| Stephen L. Collins | 4 |
- Stock Market
- Insiders
- Jason Bablak
- Company connections
